DOSSIER · 13F Holders · Q1 2026Healthcare · Pharmaceutical PreparationsDefensive growthQuality
BBIO
BRIDGEBIO PHARMA INC
479 institutions still hold BRIDGEBIO PHARMA INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 10806X102·Pharmaceutical Preparations·479 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
479 institutions reported BBIO in Q1 2026. BlackRock, Inc. leads at 11.1% of the visible book. +70 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 24
459 more holders available. Log in →